Optionele productanalyse
Met uw toestemming gebruiken we privacyvriendelijke, beperkte analyses om te begrijpen welke onderzoeksroutes werken. We gebruiken geen advertentietrackers of sessieopnamen. U kunt deze keuze wijzigen in Voorkeuren. Lees het Privacybeleid.
Ventas, Inc.'s published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $43.1B | |
|---|---|---|
| Revenue (ttm) | 6.8B | |
| Net income (ttm) | 262.1M | |
| EPS (ttm) | $0.52 | |
| Shares out | 532.3M | |
| P/E (trailing) | 155.5x | |
| P/E (forward) | 128.2x | |
| Dividend | $2.08 (2.59%) | |
| Volume | 5,342,337 | |
| Beta | 0.74 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $3.83B | $4.13B | $4.50B | $4.92B | $5.83B | +11.1% |
| Gross profit | $1.74B | $1.85B | $1.94B | $2.10B | $-344.2M | — |
| Operating income | $501.5M | $409.7M | $534.3M | $653.4M | $859.6M | +14.4% |
| Net income | $49.0M | $-47.4M | $-41.0M | $81.2M | $251.4M | +50.5% |
| EPS (diluted) | $0.13 | $-0.12 | $-0.10 | $0.19 | $0.54 | +42.8% |
| EBITDA | $1.72B | $1.62B | $1.95B | $1.94B | $2.24B | +6.9% |
| R&D | $0 | $0 | $0 | — | — | +0.0% |
| SG&A | $129.8M | $144.9M | $148.9M | $163.0M | $177.4M | +8.1% |
Recent company headlines from major financial publishers.
Under the base case, occupancy recovery proceeds steadily across the senior living portfolio, supporting projected revenue growth through FY2027. Consolidated operating margins expand moderately from FY2025 levels through FY2030 as fixed costs are absorbed. Diluted earnings per share recover through FY2027. However, ongoing capital reinvestment and debt refinancing costs across near-term debt maturities balance operational gains, supporting our Fair value of $37.49.
Under the upside case, demographic expansion accelerates senior living move-ins, while historically low construction starts in Q2 2026 create a prolonged supply shortage. Same-store senior housing operating margins and incremental flow-through expand, lifting consolidated operating profitability. Operating cash flow expands significantly, allowing Ventas to fund accretive acquisitions with internal cash flow, deleverage its debt burden, and support Potential value of $54.44.
| Ke ↓ / g → | 2.0% | 2.3% | 2.5% | 2.8% | 3.0% |
|---|---|---|---|---|---|
| 7.3% | $39.9 | $40.8 | $41.8 | $42.9 | $44.1 |
| 7.8% | $37.9 | $38.6 | $39.4 | $40.3 | $41.3 |
| 8.3% | $36.2 | $36.8 | $37.5 | $38.2 | $39.0 |
| 8.8% | $34.8 | $35.3 | $35.9 | $36.4 | $37.1 |
| 9.3% | $33.6 | $34.0 | $34.4 | $34.9 | $35.5 |
Upcoming earnings date and setup when available.
De rating die de gepubliceerde researcheditie van elke maand droeg. Een rating vergelijkt de koers op de analysedatum met de fair value; het is geen overzicht van of de inschatting juist bleek.
| Jaar | jan | feb | mrt | apr | mei | jun | jul | aug | sep | okt | nov | dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
